Clinical Study
A 2-Week Course of Enteral Treatment with a Very Low-Calorie Protein-Based Formula for the Management of Severe Obesity
Table 2
Self-reported side effects throughout the study (per-protocol population;
).
| | Side effect | Days 1–7 | Days 8–14 | | (%) | (%) |
| | Asthenia | 17 (5.1) | 6 (1.8) | | Headache | 34 (10.0) | 3 (0.9) | | Dizziness | 2 (0.6) | 1 (0.3) | | Fainting | 4 (1.2) | 1 (0.3) | | Orthostatic hypotension | 25 (7.4) | 12 (3.6) | | Heartburn | 23 (6.8) | 11 (3.3) | | Nausea | 13 (3.8) | 3 (0.9) | | Vomiting | 6 (1.8) | 2 (0.6) | | Palpitations | 4 (1.2) | 2 (0.6) | | Muscle cramps | 7 (2.1) | 13 (3.8) | | Hunger | 34 (10.1) | 12 (3.6) | | Constipation | 29 (8.6) | 37 (10.9) |
|
|
